Results 121 to 130 of about 16,341 (256)

Parvovirus B 19 (PVB19) Induced Pure Red Cell Aplasia (PRCA) in Immunocompromised Patient after Liver Transplantation [PDF]

open access: yes, 2010
Presented here is a case of human parvovirus B19 (PVB19) induced pure red-cell aplasia (PRCA) in immunocompromised patient after orthotopic liver transplantation (OLT).
Anna Mrzljak   +6 more
core   +1 more source

Acquired Pure Red Cell Aplasia Following Recombinant Erythropoietin (Darbepoetin-alfa) Therapy

open access: yesIndian Journal of Nephrology, 2019
Acquired pure red cell aplasia (PRCA) following use of recombinant erythropoietin (rEPO) is distinctly rare and sporadically reported in the literature. We discuss a case of PRCA following the usage of rEPO (darbepoetin-α) during the management of anemia
S. Padhi   +5 more
semanticscholar   +1 more source

Infrequent Replication of Parvovirus B19 and Erythrovirus Genotypes 2 and 3 among HIV-Infected Patients with Chronic Anemia [PDF]

open access: yes, 2017
We investigated the role that erythroviruses (parvovirus B19 and erythrovirus genotypes 2 and 3) play in the lives of immunosuppressed HIV-infected patients with chronic anemia.
Bernasconi, Enos   +10 more
core  

Infection of Autoreactive B Lymphocytes with EBV, Causing Chronic Autoimmune Diseases [PDF]

open access: yes, 2003
I hypothesize that human chronic autoimmune diseases are based on infection of autoreactive B lymphocytes by Epstein-Barr virus (EBV), in the following proposed scenario. During primary infection, autoreactive B cells are infected by EBV, proliferate and
Pender, Michael P.
core   +1 more source

Oncologic Emergencies: Immune-Based Cancer Therapies and Complications [PDF]

open access: yes, 2020
Cancer therapies have undergone several recent advancements. Current cancer treatments include immune-based therapies comprised of checkpoint inhibitors, and adoptive immunotherapy; each treatment has the potential for complications that differ from ...
Brém, Elizabeth   +2 more
core  

Therapeutic antibodies: current state and future trends--is a paradigm change coming soon? [PDF]

open access: yes, 2008
Antibody-based therapeutics currently enjoy unprecedented success, growth in research and revenues, and recognition of their potential. It appears that the promise of the "magic bullet" has largely been realized.
Dimitrov, Dimiter S, Marks, James D
core   +1 more source

Tacrolimus and Pure Red-Cell Aplasia [PDF]

open access: yesAmerican Journal of Transplantation, 2005
Gregoor, PS, Weimar, Willem
openaire   +2 more sources

ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides

open access: yesInternational Journal of Hematology-Oncology and Stem Cell Research, 2018
Hematopoietic stem cell transplantation (HSCT) is a useful treatment. In contrast to solid organ transplantations, the use of ABO blood group mismatch is acceptable in HSCT.
Negin Shokrgozar, Gholamhossein Tamaddon
doaj   +1 more source

Las alteraciones de la medula ósea en el perro y el gato [PDF]

open access: yes, 2001
El estudio de la médula ósea, como órgano hématopoyético, es necesario siempre que existan anomalías persistentes o no explicables en el hemograma. En este trabajo se realiza una revisión de las diferentes alteraciones que pueden presentarse en la médula
Aceña Fabián, M. Carmen   +1 more
core  

Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab

open access: yesAmerican journal of hematology/oncology, 2019
patients, but two patients required red cell transfusions. The dose of carfilzomib was also reduced to 36 mg/m for patient #1. This allowed gradual improvement of hemoglobin and partial normalization of mean cell volume over the following cycles of ...
S. Bathini   +15 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy